optical mapping Bionano Genomics Q1 Revenues Almost Triple The San Diego-based optical genome mapping instrument maker saw record consumables revenue and beat Wall Street's consensus estimate on the top line. Columbia University-led Study Highlights Bionano Optical Genome Mapping Concordance with Cytogenetics Bionano Genomics called the study, presented this week at the American College for Medical Genetics meeting, an "incredibly important milestone" for the company. Bionano Genomics Outlines Strategy for Clinical Adoption of Optical Genome Mapping Premium The company is also working on a new Saphyr system that will have 14 times higher throughput than the current one, which can analyze 5,000 human genomes per year. Bionano Genomics Q4 Revenues Grow 43 Percent Revenues in Q4 totaled $4 million, up from $2.8 million a year ago, primarily driven by the firm's recently acquired Lineagen diagnostic services business. Bionano Genomics to Raise $200M in Public Stock Offering The new fundraising effort follows on the heels of a $101.8 million public stock offering Bionano closed last week, at a price of $3.05 per share. Jan 15, 2021 Bionano Genomics Stock Soars on User Presentations, Public Stock Offering, Renewed Nasdaq Compliance Jan 8, 2021 Bionano Genomics Expects Up to 50 Percent Q4 Revenue Growth, Prices $88.5M Public Stock Offering Dec 23, 2020 Bionano Genomics' Stock Spikes on Study Showing Strength of Structural Variation Detection Tech Nov 19, 2020 Rebus Biosystems Closes $20M Series B Financing Round Nov 12, 2020 Bionano Genomics Q3 Revenues Down 33 Percent Sep 17, 2020 Praxis Genomics Bets on Bionano Optical Maps, Sequencing to Solve Complex Rare Disease Cases Premium Aug 24, 2020 Bionano Genomics Acquires Diagnostic Services Provider Lineagen for $9.6M Aug 17, 2020 Bionano Genomics Expecting Clinical Validation Studies to Drive Platform Adoption Premium Aug 13, 2020 Bionano Genomics Q2 Revenues Fall 46 Percent Jun 19, 2020 Bionano Genomics Q1 Revenues Drop 39 Percent Jun 15, 2020 Genome In a Bottle Consortium Releases Structural Variant Calling Benchmark Data Premium Apr 24, 2020 Bionano Genomics Receives Nasdaq Warning Over Low Share Price Apr 8, 2020 Oppenheimer Initiates Coverage of Bionano Genomics at Outperform Mar 12, 2020 Bionano Genomics to Publicly Offer Securities, Amends Loan Agreement Mar 5, 2020 Bionano Genomics Q4 Revenues Drop 31 Percent Nov 7, 2019 Bionano Genomics Q3 Revenues Rise 17 Percent Oct 21, 2019 Bionano Genomics Prices $18M Public Offering Sep 19, 2019 Bionano Genomics Commences Public Stock Offering Aug 8, 2019 Bionano Genomics Q2 Revenues Fall 36 Percent May 9, 2019 Bionano Genomics Q1 Revenues Rise 5 Percent Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.